PSMA-RECAP: [(177)Lu]Lu-PSMA-617 retreatment in metastatic castration-resistant prostate cancer.
- DOI
- 10.3389/fonc.2026.1831393
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1831393,
title = {PSMA-RECAP: [(177)Lu]Lu-PSMA-617 retreatment in metastatic castration-resistant prostate cancer.},
author = {Belge Bilgin G and Bilgin C and Packard AT and Burkett BJ and Oztekin ES and Thorpe MP and Childs DS and Muniz M and Stoff R and Nikanpour Y and Orme JJ and Kwon ED and Johnson GB and Sartor O and Johnson DR and Kendi AT},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1831393},
url = {https://doi.org/10.3389/fonc.2026.1831393}
}RIS
TY - JOUR TI - PSMA-RECAP: [(177)Lu]Lu-PSMA-617 retreatment in metastatic castration-resistant prostate cancer. AU - Belge Bilgin G AU - Bilgin C AU - Packard AT AU - Burkett BJ AU - Oztekin ES AU - Thorpe MP AU - Childs DS AU - Muniz M AU - Stoff R AU - Nikanpour Y AU - Orme JJ AU - Kwon ED AU - Johnson GB AU - Sartor O AU - Johnson DR AU - Kendi AT PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1831393 UR - https://doi.org/10.3389/fonc.2026.1831393 ER -
APA
G, B. B., C, B., AT, P., BJ, B., ES, O., MP, T., DS, C., M, M., R, S., Y, N., JJ, O., ED, K., GB, J., O, S., DR, J., & AT, K. (2026). PSMA-RECAP: [(177)Lu]Lu-PSMA-617 retreatment in metastatic castration-resistant prostate cancer.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1831393
Source records
- pubmed · retrieved 2026-09-25T13:53:58.881Z